INTERNATIONAL PATENT: SYNNOVATION THERAPEUTICS, INC. FILES APPLICATION FOR "HETEROCYCLIC COMPOUNDS AS MODULATORS OF TNFA ACTIVITY"

GENEVA, March 4 -- SYNNOVATION THERAPEUTICS, INC. (200 Powder Mill Road E500-1801Wilmington, Delaware 19803) filed a patent application (PCT/US2025/043164) for "HETEROCYCLIC COMPOUNDS AS MODULATORS OF TNFA ACTIVITY" on Aug 22, 2025. With publication no. WO/2026/044218, the details related to the patent application was published on Feb 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HE, Chunhong (c/o Synnovation Therapeutics, Inc.200 Powder Mill Road E500-1801Wilmington, Delaware 19803), MUKAI, Ken (c/o Synnovation Therapeutics, Inc.200 Powder Mill Road E500-1801Wilmington, Delaware 19803...